Atelerix Company

Atelerix has a transformative technology for the storage and transport of viable cells at room temperature, overcoming the barriers and limitations presented by the current need for cryo-shipping. We do this using our patented process of encapsulating the cells in a natural hydrogel for safe shipment and storage. The cells can be recovered when needed by the addition of a gentle, cell-friendly buffer. This means: Predictability and reliability in drug discovery models and for cells used as therapies Customers can use cells and assays immediately on arrival No need for cryopreservation, nor need for cytotoxic or animal-derived supplements Cells retain their natural state and are not damaged nor altered.
Technology: Cell Therapies
Industry: Personalized Medicine
Headquarters: Newcastle, Newcastle upon Tyne, United Kingdom
Founded Date: 2006
Employees Number: Undisclosed
Funding Status: Seed

Visit Website
mick.mclean@atelerix.co.uk
@AtelerixLtd
Register and Claim Ownership